Li X - Search Results

1

Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.

Zhao M, Guo Z, Zou YH, Li X, Yan ZP, Chen MS, Fan WJ, Li HL, Yang JJ, Chen XM, Xu LF, Zhang YW, Zhu KS, Sun JH, Li JP, Jin Y, Yu HP, Duan F, Xiong B, Yin GW, Lin HL, Ma YL, Wang HM, Gu SZ, Si TG, Wang XD, Zhao C, Yu WC, Guo JH, Zhai J, Huang YH, Wang WY, Lin HF, Gu YK, Chen JZ, Wang JP, Zhang YM, Yi JZ, Lyu N. Zhao M, et al. Among authors: li hl, li x, li jp. Hepatol Int. 2024 Feb;18(1):4-31. doi: 10.1007/s12072-023-10599-6. Epub 2023 Oct 21. Hepatol Int. 2024. PMID: 37864725

2

Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma.

Xin Y, Zhang X, Liu N, Peng G, Huang X, Cao X, Zhou X, Li X. Xin Y, et al. Among authors: li x. Hepatol Int. 2023 Jun;17(3):753-764. doi: 10.1007/s12072-023-10502-3. Epub 2023 Apr 10. Hepatol Int. 2023. PMID: 37038024

3

Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial).

Zhu HD, Li X, Sun JH, Zhu X, Liu ZY, Li HL, Lu J, Yan ZP, Shao GL, He XF, Chao M, Lu LG, Zhong BY, Li R, Zhang Q, Teng GJ. Zhu HD, et al. Among authors: li hl, li x, li r. Cardiovasc Intervent Radiol. 2024 Mar;47(3):325-336. doi: 10.1007/s00270-024-03666-4. Epub 2024 Feb 27. Cardiovasc Intervent Radiol. 2024. PMID: 38413420 Free PMC article. Clinical Trial.

4

How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles.

Fu Y, Zeng CH, An C, Liu Y, Shin JH, Li X. Fu Y, et al. Among authors: li x. Cancers (Basel). 2023 Feb 19;15(4):1324. doi: 10.3390/cancers15041324. Cancers (Basel). 2023. PMID: 36831664 Free PMC article. Review.

5

Clinical outcomes of hepatocellular carcinoma patients after hepatectomy treated with TACE in combination with sorafenib: a propensity score matched analysis.

Li Y, Zhao R, Li X. Li Y, et al. Among authors: li x. Transl Cancer Res. 2023 May 31;12(5):1088-1099. doi: 10.21037/tcr-22-2784. Epub 2023 May 8. Transl Cancer Res. 2023. PMID: 37304537 Free PMC article.

6

Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy.

Yang H, Cong T, Luo Y, Yang C, Ren J, Li X. Yang H, et al. Among authors: li x. J Hepatocell Carcinoma. 2024 Jan 24;11:175-189. doi: 10.2147/JHC.S444530. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 38283695 Free PMC article.

7

A multicenter case-controlled study on laparoscopic hepatectomy versus microwave ablation as first-line therapy for 3-5 cm hepatocellular carcinoma in patients aged 60 and older.

Wang Z, Zhang H, Meng Q, Zhang DZ, Wu SS, Hong ZX, He GB, Yang H, Xiang BD, Li X, Jiang TA, Li K, Tang Z, Huang F, Lu M, Liu C, Yu XL, Cheng ZG, Liu FY, Han ZY, Dou JP, Yu J, Liang P. Wang Z, et al. Among authors: li x, li k. Int J Surg. 2024 Mar 1;110(3):1356-1366. doi: 10.1097/JS9.0000000000000839. Int J Surg. 2024. PMID: 38320101 Free PMC article.

8

Systemic inflammation influences the prognosis of patients with radically resected non-small cell lung cancer and correlates with the immunosuppressive microenvironment.

Wang P, Wang S, Sun Z, Li H, Zhao Y, Li Y, Yang F, Wang J, Chen K, Qiu M, Li X. Wang P, et al. Among authors: li y, li h, li x. Int J Cancer. 2023 Aug 15;153(4):826-842. doi: 10.1002/ijc.34547. Epub 2023 Apr 26. Int J Cancer. 2023. PMID: 37186387

9

The Prognostic Value of TTF-1/NKX2-1 in Lung Squamous Cell Carcinoma.

Liao Y, Yang F, Li X, Chen K, Wang J. Liao Y, et al. Among authors: li x. Appl Immunohistochem Mol Morphol. 2023 Jul 1;31(6):414-420. doi: 10.1097/PAI.0000000000001136. Epub 2023 Jun 13. Appl Immunohistochem Mol Morphol. 2023. PMID: 37338116 Free PMC article.

10

Shenqi Fuzheng Injection Combined With Chemotherapy for Gastric Cancer: An Overview of Systematic Reviews and Meta-Analyses.

Xu J, Li X, Dong Q, Lv L, Yun Z, Hou L. Xu J, et al. Among authors: li x. Integr Cancer Ther. 2023 Jan-Dec;22:15347354231210811. doi: 10.1177/15347354231210811. Integr Cancer Ther. 2023. PMID: 38006245 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167,621 results

Search Page